I received a response from Emerging Growth. Please share with Joe and Todd.


We will reach out to them with an invitation. Do you have a contact there?

The request to have a company present on our conference always comes best from a shareholder or potential investor.

I run the conferences.

Give them my info and have them call me. I will put them on

Thanks.



________________________________________
Charles T. Tamburello
EmergingGrowth.com
Office: 305-330-1985
Fax: 305-330-1986
Mobile: 305-323-5687
eMail: CTT@EmergingGrowth.com
Skype: CTTamburello

On Sep 12, 2021, at 10:34 AM, Michael Bliss <ridgebackmix@gmail.com> wrote:

Good morning,

It would be wonderful to see you feature Generex/ NuGenerex Biotechnology ( GNBT).

https://generex.com/

https://nugenerexio.com/

Although the stock price has been beaten down during Covid, they have a number of things in the works - including their Complete Vaccine for Covid19 utilizing the Ii-Key platform which already has 10yr safety data from on ongoing triple negative breast cancer trial.

Respectfully,

Michael Bliss
-Chicago, IL